Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Rambam Health Care Campus
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Clinical Rating Scale for Tremor
Study Overview
Brief Summary
The goal of this retrospective observational study is to describe the efficacy of focused ultrasound ventral-intermediate nucleus thalamotomy in patients with atypical parkinsonism.
- Is this treatment efficacious in patients with multiple system atrophy?
- Is this treatment efficacious in patients with diffuse Lewy Body Dementia? Data will be collected from patients charts.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients that did not underwent FUS ventral-intermediate nucleus thalamotomy
- •Patients that underwent FUS ventral-intermediate nucleus thalamotomy and do not suffer from MSA or DLBD
Outcomes
Primary Outcomes
Clinical Rating Scale for Tremor
Time Frame: baseline, pre-procedure, 1 month, 6 months and 1 year following procedure
tremor assessment by Clinical Rating Scale for Tremor. Scores ranging from 0 to 156, with higher scores indicating more severe tremor.
Secondary Outcomes
No secondary outcomes reported
Investigators
Ilana Schlesinger
Director Movement Disorders Institute, clinical senior lecturer, Chair of Neurology, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Haifa, Israel
Rambam Health Care Campus
